SA
Sign upLog In

Regeneron Pharmaceuticals (REGN)

Depreciation & Amortization

$123.70M

Quarterly · Period ending: · USD

REGN logo

REGN Depreciation & Amortization

Latest reported$123.70M
REGN Quarterly Depreciation & Amortization ($200.00K → $123.70M)
High-resolution chart · PNG

REGN depreciation & amortization history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Depreciation & Amortization — Quarterly (USD)
Period endingDepreciation & Amortization (USD)
123,700,000
123,200,000
145,000,000
136,700,000
135,100,000
126,900,000
126,400,000
121,700,000
120,700,000
114,100,000
113,000,000
105,400,000
103,100,000
99,500,000
100,100,000
92,600,000
74,400,000
74,300,000
74,500,000
73,200,000
71,100,000
67,400,000
61,700,000
59,300,000
58,800,000
56,100,000
54,300,000
52,900,000
52,100,000
51,000,000
42,759,000
35,441,000
33,642,000
36,358,000
34,507,000
37,719,000
35,126,000
38,115,000
28,900,000
27,839,000
25,029,000
22,977,000
22,910,000
20,674,000
15,298,000
16,027,000
14,135,000
14,005,000
13,016,000
11,530,000
11,292,000
10,803,000
9,702,000
9,407,000
9,778,000
9,329,000
9,417,000
8,416,000
7,926,000
8,276,000
7,902,000
6,978,000
6,086,000
4,894,000
4,524,000
4,183,000
4,935,000
3,590,000
2,998,000
2,724,000
2,626,000
2,774,000
2,941,000
2,946,000
2,899,000
2,859,000
2,874,000
2,855,000
3,396,000
3,708,000
3,690,000
3,798,000
3,880,000
3,935,000
3,831,000
3,858,000
3,916,000
3,876,000
3,797,000
3,773,000
4,314,000
3,656,000
2,679,000
2,288,000
2,049,000
2,169,000
2,228,000
2,008,000
1,810,000
1,519,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.